Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Methodist J.C. Walter Jr. Transplant Center - Houston, TX

Total: 61

  1. Torre-Amione G, Anker SD, Bourge RC, Colucci WS, Greenberg BH, Hildebrandt P, Keren A, Motro M, Moye LA, Otterstad JE, Pratt CM, Ponikowsk P, Rouleau JL, Sestier F, Winkelman BR, Young JB: Results of non-specific immunomodulation Therapy in Chronic Heart Failure (ACCLAIM Trial): A Placebo-controlled Randomised Trial. Lancet. 2008 January 19’ 371:228-236.

  2. Jahanyar J, Youker KA, Torre-Amione G, Koerner MM, Bruckner B, Noon GP, Loebe M.: Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure. J Heart Lung Transplant. 2008 Jul;27(7):701-9. Epub 2008 Jun 2.

  3. Jahanyar J, Koerner MM, Loebe M, Youker KA Torre-Amione G, Noon GP.: The role of mast cells after solid organ transplantation. Transplantation. 2008 May 27;85(10):1365-71.

  4. Busch J, Wojciechowski Z, Torre-Amione G, Loebe M.: Off-pump exchange of short-term percutaneous ventricular assist device (VAD) to long-term implantable VAD in severe coagulopathy and multi-organ failure. J Heart Lung Transplant. 2008 May;27(5):572-4. Epub 2008 Mar 10.

  5. Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF.: Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J. 2008 May;29(10):1283-9. Epub 2008 Apr 2.

  6. Celis R, Torre-Martinez G, Torre-Amione G.: Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Curr Opin Cardiol. 2008 May;23(3):254-60.

  7. Chen D, Assad-Kottner C, Orrego C, Torre-Amione G.: Cytokines and acute heart failure. Crit Care Med. 2008 Jan;36(1 Suppl):S9-16. Review.

  8. Assad-Kottner C, Chen D, Jahanyar J, Cordova F, Summers N, Loebe M, Merla R, Youker K, Torre-Amione G .: The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times. J Card Fail. 2008 Dec;14(10):839-43. Epub 2008 Nov 5.

  9. Khosla UM, Mitch WE. “Dietary Protein restriction in the Management of Chronic Kidney Disease.” (in press).

  10. Chen D, Assad-Kottner C, Orrego C, Torre-Amione G. Cytokines and Acute Heart Failure. Crit Care Med. 2008 Jan;36(1 Suppl):S9-16. Review. ISSN: 0090-3493

  11. Guillermo Torre-Amione, Carlos M. Orrego, Christian Kottner-Assad, Chris Levecque, Nashwa Khalil, Rene Celis, Keith A. Youker, Jerry Estep. Evaluation of humoral immunity in heart failure: Plasmapheresis potential therapeutic strategy. (Circulation 2009, in review)

  12. Knight R, Kerman RH, McKissick E, Lawless A, Podder H, Katz SM, Van Buren CT, Kahan BD. Corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. Clinical Transplantation. 2008; 5: 645.

  13. Rodriguez L, Knight RJ, Heptulla RA. Assessment of glycemic excursions after simultaneous pancreas-kidney and kidney alone transplantation. Submitted for publication.

  14. Ramasubbu, K, Estep, J, White, DL, Deswal, A, Mann, DL: Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. JACC 2008; 51(4): 415-26.

  15. Estep, JD, Diagnosis of heart failure with preserved ejection fraction. JMDHVC 2008; volume 4, number 3: 8-12.

  16. Jerry D. Estep, MD, FACC , Htut K.Win, MD, Tharak Yarrabolu, MD, O. H. Frazier, MD and Raymond F. Stainback MD. Pump speed change echocardiograms: An observational study using conventional transthoracic echocardiography to monitor myocardial function with increasing continuous axial flow left ventricular assist device support. JACC Imaging (under review).

  17. Yeyati NL, Fellet A, Arranz C, Balaszczuk AM, Adrogué HJ. Amiloriide-sensitive and insensitive kaliuresis in advanced chronic kidney disease. Journal of Nephrology. J Nephrol 2008;21:93-98.

  18. Madias NE, Adrogué HJ. Respiratory Acidosis and Alkalosis. In: Primer on Kidney Diseases, Fifth Edition. Greenberg A (ed). (in press).

  19. Adrogué HJ. Shared Primacy of Sodium and Potassium in the Pathogenesis of Hypertension. Proceedings of the XV Argentinian Congress of Hypertention. April 17-19, 2008, Buenos Aires, Argentina.

  20. Shanda H. Blackmon, MD, MPH, Ashish R. Patel, MD, Brian A. Brucnkner, MD, Erik A. Beyer, MD, David C. Rice, MB, BCh, Ara A. Vaporciyan, MD, Zbigniew Wojciechowski, MD, Arlene M. Correa, PhD, Michael J. Reardon, MD. “Cardiac Autotransplantation for Malignant or Complex Primary Left-Heart Tumors. Texas Heart Institute Journal 2008: Vol 35 (3):296-300

  21. Culp Jr. WC, Beyer EA. Three-dimensional transesophageal echocardiographic imaging of a thoracic aortic dissection. Journal of Cardiovascular Medicine. 2008;9:862-863

  22. Brian A. Bruckner, Erik A.K. Beyer, Jaime Aburto, Michael J. Reardon, Jon-Cecil (J.C.) Walkes. Impact of Minimally Invasive Mitral Valve Surgery. Journal the Methodist DeBakey Heart & Vascular Center (JMDHVC) 2008:Vol. 4(2) 30-32

  23. Beyer EA , Lam BK, Lee R. Minimally Invasive Bipolar Radiofrequency Ablation of Lone Atrial Fibrillation: Early Multicenter Results. Journal of Thor and CV Surgery. In press.

  24. Culp W, Beyer EA. 3D Echocardiogram of Type A Aortic Dissection. The J of CV Medicine. In Press.

  25. Adam R, de Hass RJ, Wicherts DA, Aloia TA, Azoulay D, Bismuth H, Castaing D. Is hepatic resection justified in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 26(22): 3672-80, 2008.

  26. Becker NS, Rodriguez JA, Barshes NR, O’Mahony CA, Goss JA, Aloia TA. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 12:117-22, 2008.

  27. Rodriguez JA, Becker NS, O’Mahony CA, Goss JA, Aloia TA. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg 12:110-6, 2008.

  28. Short, M, Aloia TA, Ho, V. Hospital volume, surgeon volume, and patient costs for cancer surgery. Medical Care 46:718-25, 2008.

  29. Adam, R, Wicherts, WA, de Haas, RA, Lévi, F, Aloia TA, Paule, B, Bralet, MP, Kunstlinger, F, Azoulay, D, Castaing, D. Complete pathological response after preoperative chemotherapy for colorectal liver metastases: predictive factors and long-term survival. J Clin Oncol 26(10): 1635-41, 2008.

  30. Aloia TA, Fahy, BN. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases. Clin Colorectal Cancer 7(3)197-201, 2008.

  31. Short, M, Aloia TA, Ho, V. Certificate of need regulations and the availability and use of cancer resections. Ann Surg Oncol 15(7): 1837-1845, 2008.

  32. Fischer, CP, Bass, B, Fahy, B, Aloia, T. Transampullary pancreatic duct stenting decreases pancreatic fistula rate following left pancreatectomy. Hepatogastroenterology 55(81): 244-8, 2008.

  33. Chirica M, Scatton O, Massault PP, Aloia T, Randone B, Dousset B, Legmann P, Soubrane O. Treatment of stage IVa hepatocellular carcinoma: Should we reappraise the role of surgery? Arch Surg 143(6):538-43, 2008.

  34. Beasley, GM, Petersen, RP, Yoo, J, McMahon, N, Aloia, T, Petros, W, Sanders, G, Cheng, TY, Pruitt, SK, Seigler, H, Tyler, DS. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol (in press)

  35. Patel SJ, Duhart BT Jr, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction. Transplantation 2008 Jul 27;86(2):313-20.

  36. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Veldhuisen, PV for the Astellas Corticosteroid Withdrawal Study Group. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008 Oct; 248(4):564-77.

  37. Gaber AO, Kahan BD, Van Buren C, Schulman S, Scarola J, Neylan JF, Sirolimus High-Risk Study Group. Comparison of Sirolimus plus Tacrolimus versus Sirolimus plus Cyclosporine in high-risk renal allograft recipients: results from an open-oabel randomized trial. Transplantation, 2008 Nov 15;86(9): 1187-95.

  38. Sabek OM, Cowan P, Fraga DW, Gaber AO. The effect of isolation methods and theuse of different enzymes on islet yield and in vivo function. Cell Transplant, 2008:17(7):785-92.

  39. Soltero L, Carbajal H, Xu J, McCarthy J, Suki WN, Gaber AO, Adrogue HE. Decreased survival in kidney transplant patients with pre-transplant monoclonal gammopathy. (submitted)

  40. Hastings MC, Ault B, Gaber AO, Wyatt RJ, DeBon M, Bush AJ. Use of an objective definition of delayed graft function (DGF) in pediatric recipients of renal transplantation. AJN, (submitted)

  41. Fischer CP , Doria C, Wood C, Li MP, Marra S, Hart J. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Current Medical Research and Opinion, 2008. Mar;24(3):785-94

  42. Fischer CP , Bass B, Fahy B, Aloia T. Transampullary pancreatic duct stenting decreases pancreatic fistula rate following left pancreatectomy. Hepatogastroenterology, 2008 Jan-Feb;55(81):224-8.

  43. Adams SD, Stephens NA, Cohen AM, Hong J and Fischer CP. Treatment of hemobilia via trans-catheter injection of fibrin glue. JVIR. In press.

  44. Fischer CP , Aloia TA, Fahy BN, BL Bass, AO Gaber, RM Ghobrial. Timing of Referral Impacts Surgical Outcomes in Patients Undergoing Repair of Bile Duct Injuries. In Press, HPB. 2008.

  45. Fischer CP , Aloia TA, Fahy BN, Jones SL, Moore L, Bass BL. Optimizing outcome measurement in pancreatic surgery: Can NSQIP measure up? Submitted to JOGS.,2008.

  46. Fischer CP, Torres I, Rosenberg W, and Duan X. Solid Pseudopapillary Tumor of the Left and Right Pancreas: Clinical Correlates and Literature Review. Submitted World Journal of Surgical Oncology, 2008.

  47. Fischer CP, Albala DM, Wood CG, GainesBA. Safety and Effectiveness of a Fibrin Sealant Compared With an Absorbable Hemostat for Achieving Hemostasis in Soft Tissue During Retroperitoneal or Intra-abdominal Surgery. Submitted Journal of Thrombosis and Hemostasis, 2008.

  48. Fischer CP. Gene Therapy for Pancreatic Cancer – A Work in Progress. In Progress., Archives of Pathology, 2008.

  49. Aburto J, Bruckner BA, Blackmon S, Reardon MJ. “Renal Cell Carcinoma Metastatic to the Left Ventricle: A Case Report.” Accepted by Texas Heart Institute Journal, April, 2008.

  50. Bruckner BA, Jacob L, Gregoric I, Loyalka P, Kar B, Cohn W, Frazier O.”Clinical Experience with the Tandem Heart Percutaneous Ventricular Assist Device as a Bridge to Cardiac Transplantation.” Accepted by Texas Heart Institute Journal, April, 2008.

  51. Gregoric I , Jacob L, La Francesca S, Bruckner BA, Cohn WE, Loyalka P, Kar B, Frazier O. ”The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge).” Texas Heart Institute Journal. 2008;35(2):125-9.

  52. Jahanyar J, Youker KA, Torre-Amione G, Koerner MM, Bruckner BA, Noon GP, Loebe M. “Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.” J Heart Lung Transplant. 2008 Jul;27(7):701-9.

  53. Gregoric ID, Bruckner BA, Jacob L, Kar B, Cohn WE, La Francesca S, Frazier OH. “Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Ann Thorac Surg. 2008 May;85(5):1646-9.

  54. Shanda H. Blackmon, MD, MPH, Ashish R. Patel, MD, Brian A. Bruckner, MD, Erik A. Beyer, MD, David C. Rice, MB, BCh, Ara A. Vaporcivan, MD, Zbigniew Wojciechowski, MD, Arlene M. Correra, PhD, Michael J. Reardon, MD. “Cardiac Autotransplantation for Malignant or Complex Primary Left-Heart Tumors.” Tex Heart Inst J 2008; 35 (3): 296-300

  55. HLA Antibody identification and prediction of crossmatch results. Afzal Nikaein, Timothy Baker, Karen Nelson, Geoffrey Land, Susie Leffell, Wida Cherik. 2009. OPTN/UNOS Histocompatibility Committee. Submitted to Transplantation. In Press

  56. Permpongkosol S, Link RE, Kavoussi LR, Solomon SB: Temperature measurements of the low-attenuation radiographic ice ball during CT-guided renal cryoablation. Cardiovasc Intervent Radiol 31(1):116–121, 2008.

  57. Levinson AW, Bagga HS, Pavlovich CP, Mettee LZ, Ward NT, Link RE, Su LM: The impact of prostate size on urinary quality of life indexes following laparoscopic radical prostatectomy. J Urol 179(5):1818–1822, 2008.

  58. Levinson AW, Pavlovich CP, Ward NT, Link RE, Mettee LZ, Su L-M: Association of surgeon’s subjective characterization of nerve sparing quality with potency following laparoscopic radical prostatectomy. J Urol 179(4):1510–1514, 2008.

  59. Colen J, Link RE: Basic genital dermatology for the urologist. Contemp Urol (in press), 2008.

  60. Boon JR, Salas N, Avila D, Boone TB, Lipshultz LI, Link RE: Construct validity of the pig intestine model in the simulation of laparoscopic urethrovesical anastamosis: Tools for objective evaluation. J Endourol (in press), 2009

  61. G. Torre-Amione, Wissam H. Zade Asfahani, N.S. Kleiman, M. Loebe, G.P. Petrov. Surgical Considerations on the Use of the Percutaneous Ventricular Assist Device TandemHeart in Critical Aortic Valve Stenosis. Thorac Cardiov Surg. 2008 Feb;56: 1-2